Views & Analysis Nontuberculous mycobacteria – an emerging public health prob... The challenge of treating Nontuberculous mycobacteria.
Views & Analysis Collaboration the key to success in respiratory research Lung research needs support as fifth of UK diagnosed with respiratory condition.
News Biomarker trial to show drug value in rare lung disease Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.
News Lexicon's type 1 diabetes drug voted down by FDA adcomm It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
